Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. - Wikidata - wikimedia - TriplyDB

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.

http://www.wikidata.org/entity/Q44801183

about

Cloak and Dagger: Alternative Immune Evasion and Modulation Strategies of Poxviruses Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox Antibodies against viruses: passive and active immunization Wanted, dead or alive: New viral vaccines Structural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5 Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.Generation of recombinant vaccinia viruses via green fluorescent protein selection Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination.Diversity in the acute CD8 T cell response to vaccinia virus in humans.Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection Surviving mousepox infection requires the complement system Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies Comparison of monkeypox viruses pathogenesis in mice by in vivo imaging New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens.A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response.T cell inactivation by poxviral B22 family proteins increases viral virulence.A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection The immunology of smallpox vaccines.Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus.Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.How advances in immunology provide insight into improving vaccine efficacy.Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease.A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.Interferon function is not required for recovery from a secondary poxvirus infection.Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.Epithelial immunization induces polyfunctional CD8+ T cells and optimal mousepox protection.A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.Antiviral immunity following smallpox virus infection: a case-control study.The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies.Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin

P2860

Q26797325-7D994115-98BA-43F5-A6AA-AEDAE057737B Q27325586-9812DCB7-D3A5-4F07-B656-1017281A685E Q27346800-F15D57DB-A74B-4905-B8C4-BCA95FBDFB1B Q27346933-EE6FDD86-9378-4EAB-8EDD-449095E488ED Q27489392-B4E92110-DB02-4C73-A5DA-A1CF9BA44BB9 Q27489979-11F83F52-7ACF-464D-9465-BC9E6508DD59 Q27679281-5DBD224A-9E54-4A50-B6E4-FB3A3B9F794C Q30532861-1CC59297-040E-4262-976B-67DCA61975CC Q30584398-ACAB19AF-A9F3-412F-AC5B-54AD36A31749 Q30857503-1F0087A0-719F-4D1C-99F0-1A45A3ADC9B3 Q30994031-3E1F9A9C-4B2D-4A8F-8876-DBB699CB0EA5 Q33227607-2DAB9B1C-C904-4C27-86C8-A6FD2D992D57 Q33302672-081F2AFA-94D8-48E0-8E29-65BB7A924C1C Q33396210-778AD046-9E73-45A6-B1A0-A40DE1651C5D Q33440600-71656314-09E9-4B52-826A-65DE59D0FF6A Q33492317-81D70B69-A28B-46A4-9AB8-34182465BEE2 Q33508318-DD85EC99-A8AA-43F6-8AB6-1792369E4EFA Q33573571-3B12AB61-1016-43DF-B9B8-BF5D9796159B Q33578985-6D605D3E-CF98-4FD3-B10B-10ABB56828AF Q33618867-6F969DC8-82F6-4264-B20E-C9D2739455CC Q33624420-EF7350E9-86E2-47BB-B149-F0A05D0B9108 Q33625383-80B71DD2-8219-4E8F-8053-DD8EE8D15DD4 Q33679943-233DBECD-0124-486B-A973-E28C6A3A7A6E Q33700318-64F7870D-D76C-4C63-BEDB-D5FAB7D209D5 Q33815680-645180E2-2E8E-4622-A16A-7463756A7E2F Q33892570-5522C067-22B6-42E1-A2EB-2C721C743F03 Q33896995-C6A97133-78C6-4D16-B371-1CF2BD8D4B57 Q33900244-0A55929B-2DE5-4BFB-AF50-19B138EEAE11 Q33905188-9FC8CF6D-6506-4235-8232-7FD6A57BB957 Q33936717-C17D6858-E0FC-4503-9C86-82C7C32E8A4B Q33943914-D99923CE-7C60-49AC-89CB-E17508676E12 Q33967713-801EB665-D3FB-4040-A171-E30636EDAE1F Q34059189-6DC26004-D778-4755-AB3E-6B99235E1D64 Q34126697-2B7FA39A-7BB6-4DA3-B83B-2DE9642EBBB2 Q34188464-72BC287D-2F32-45AA-B265-3DA42423AD73 Q34416523-2939CDE8-7F45-461E-973E-E77FF31DE23A Q34428899-6659F868-5A04-4993-9CD4-2F90CE2CF88D Q34469836-80504657-79D4-41FA-9320-06AB6AC0A021 Q34478724-B59ABDC6-2B97-435C-8E77-B4BE5D81DA0A Q34484027-97A17639-62AF-4DED-83B6-90AE180CF39F

P2860

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.

http://www.wikidata.org/entity/Q44801183

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Smallpox vaccine-induced antib ...... ction against monkeypox virus.

@en

Smallpox vaccine-induced antib ...... ction against monkeypox virus.

@nl

type

label

Smallpox vaccine-induced antib ...... ction against monkeypox virus.

@en

Smallpox vaccine-induced antib ...... ction against monkeypox virus.

@nl

prefLabel

Smallpox vaccine-induced antib ...... ction against monkeypox virus.

@en

Smallpox vaccine-induced antib ...... ction against monkeypox virus.

@nl

P1433

Q44801183-E0AB9B65-E2B9-436D-9616-208516215FB5

P1476

Q44801183-E9DC6F36-DF75-4C2C-B913-8CCF6F6DD066

P2093

Q44801183-0127CB5A-3AFD-4763-B5C6-33E0B2DA5B37

Q44801183-144DF2C3-82FB-4782-8E18-0D34B267C489

Q44801183-18C2BD6E-7029-4257-B6DD-042547D441EF

Q44801183-3CDAD16E-13AB-4E79-94D3-09E752659F51

Q44801183-44218F3D-F6A8-4891-A5D8-ECEE2214EADA

Q44801183-4D5A40D8-B482-42D5-A17E-50C9AAA8F18D

Q44801183-55B19778-12B9-498B-8A26-99140B500798

Q44801183-5AF6881C-D7C7-4114-B6A2-004BE73F6DAD

Q44801183-62F00167-5A03-4A2F-93AF-7E3DB14E6CEF

Q44801183-84BD3EA5-85AC-4259-A20C-18E83A38AB45

P2860

Q44801183-06D08F57-4B65-4524-874E-E2B1DA534295

Q44801183-4BCA7301-E203-4E6D-836D-9B29E69974FB

Q44801183-543A03EF-C913-42A3-A24D-E8DA8AA37561

Q44801183-6EE72ABC-12C1-409A-B7B9-4E706A89887F

Q44801183-7A5A5603-320D-4AF3-8624-96222AEB71B2

Q44801183-7C7F2AD5-7FAA-4C33-9BC9-133812B4D6E2

Q44801183-842BC4C8-D0F3-47A4-ACD3-EF81611AAA16

Q44801183-987A2A31-2D9F-4C37-9970-E39B39F77664

Q44801183-A546A3CA-0CE9-4EF9-8E3E-F7A691AE5B4F

Q44801183-AB372F89-DBA5-452E-BC99-6096D8EA25D0

P2888

Q44801183-ECF997CA-FF22-4415-B924-6F821CD1C23B

P304

Q44801183-52106B35-70E0-4D4E-A8F7-B7362C7D8C37

P31

Q44801183-F4E800CB-4B89-43DD-B88C-33A8298A1FBD

P356

Q44801183-6E4E950C-90C1-4A16-8246-75A9555B1BCD

P407

Q44801183-BFDB8108-0AD2-4389-BA39-D15A7FDAD53B

P433

Q44801183-6D500F59-DC34-41C9-9D51-372CE2DB6A3C

P478

Q44801183-F2F31373-D1AF-4756-918C-FE9011C3669B

P50

Q44801183-3E48E76C-6C35-4A65-AC33-5D2A08DEC2ED

P577

Q44801183-E83A5068-4710-4D61-A1CC-034BE65C64A2

P5875

Q44801183-C55F9D54-B22D-4033-AAB4-59BFD9E67191

P6179

Q44801183-938CB353-3C7A-456E-99C7-A27DDC76621B

P698

Q44801183-38588C10-096C-403D-A211-8C60B595C731

P921

Q44801183-38663C34-744E-423D-A32B-1E90AE57FFDA

Q44801183-761B3F0B-563B-4186-87EC-36591CEEA9A7

P356

P1433

Nature Medicine

P1476

Smallpox vaccine-induced antib ...... ction against monkeypox virus.

@en

P2093

Aysegul Nalca

http://www.w3.org/2001/XMLSchema#string

Chris A Whitehouse

http://www.w3.org/2001/XMLSchema#string

Dorothy Scott

http://www.w3.org/2001/XMLSchema#string

Genoveffa Franchini

http://www.w3.org/2001/XMLSchema#string

Hana Golding

http://www.w3.org/2001/XMLSchema#string

Jody Manischewitz

http://www.w3.org/2001/XMLSchema#string

Joern E Schmitz

http://www.w3.org/2001/XMLSchema#string

Keith A Reimann

http://www.w3.org/2001/XMLSchema#string

Lisa R King

http://www.w3.org/2001/XMLSchema#string

Mike Bray

http://www.w3.org/2001/XMLSchema#string

P2860

Smallpox as a Biological Weapon

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus

Progressive vaccinia.

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.

A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody.

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

Control of influenza and poliomyelitis with killed virus vaccines.

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.

P2888

P304

740-747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1261

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7790523

http://www.w3.org/2001/XMLSchema#string

P6179

1004694985

http://www.w3.org/2001/XMLSchema#string

P698

15951823

http://www.w3.org/2001/XMLSchema#string

P921